Cargando…
Gene Therapies for Primary Immune Deficiencies
Gene therapy is an innovative treatment for Primary Immune Deficiencies (PIDs) that uses autologous hematopoietic stem cell transplantation to deliver stem cells with added or edited versions of the missing or malfunctioning gene that causes the PID. Initial studies of gene therapy for PIDs in the 1...
Autores principales: | Kohn, Lisa A., Kohn, Donald B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946985/ https://www.ncbi.nlm.nih.gov/pubmed/33717203 http://dx.doi.org/10.3389/fimmu.2021.648951 |
Ejemplares similares
-
Primary Immune Deficiency: Patients’ Preferences for Replacement Immunoglobulin Therapy
por: Gonzalez, Juan Marcos, et al.
Publicado: (2022) -
Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey
por: Chan, Alice Y., et al.
Publicado: (2020) -
Primary Immune Deficiencies – Principles of Care
por: Chapel, Helen, et al.
Publicado: (2014) -
Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases
por: Ballow, Mark, et al.
Publicado: (2022) -
Editorial: EBV Infection and Human Primary Immune Deficiencies
por: Cohen, Jeffrey I., et al.
Publicado: (2020)